Sidebar

Exclusive Reports

29
Fri, Mar

Lassa Fever Cases Drop Down - NCDC

Top News
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Following the widespread attack of Lassa fever in the Country, the Federal Government of Nigeria has announced a decline in the number of new cases.

Making the disclosure at a news conference in Abuja, Chief Executive Officer, Nigeria Centre for Disease Control (NCDC), Dr. Chikwe Ihekweazu, said that the country had witnessed a reduction in the number of people who have died from the disease compared to 2018.

Ihekweazu added that the NCDC and its partners had continued to sustain response activities in states across the country, despite progress made so far. “An outbreak of Lassa fever was declared in Nigeria on Jan. 21, 2019. Since then, 420 confirmed cases and 93 deaths have been reported in 21 states. He noted that following the large Lassa fever outbreak in 2018; the NCDC together with partners instituted five key measures to ensure improved preparedness in 2019.

According to the NCDC boss, he revealed that the agency have developed new case management guidelines, initiated a Lassa fever Research Consortium and hosted an International Conference on Lassa fever to share knowledge adding that the Centre also supported full availability of drugs, personal protective equipment, laboratory reagents and other supplies required for case management and diagnosis of Lassa fever.

He observed this year, there has been no single stock-out reported in any state.

“In January 2019, NCDC hosted the first Lassa fever International Conference. This brought together the largest gathering of researchers and professionals to discuss progress on Lassa fever.

“Importantly, Nigeria introduced her national Lassa fever research plan and has been recognised as one of the leading stakeholders in global Lassa fever research.

“Over the last six months, progress has been made in this area especially in discussions around Lassa fever vaccines. In the next one year, Nigeria is expected to be part of clinical trials towards the development of Lassa fever vaccines,’’ he said.

The CEO pointed out that the progress recorded in the response to the 2019 Lassa fever outbreak including an early decline in the number of new cases and reduced case fatality have been attributed to various factors.

“This includes the early deployment of One-Health national Rapid Response Teams (RRTs), improvement of functions in Lassa fever treatment centers, revision of case management guidelines, and enforcement of environmental sanitation in some states.

He, however, stressed the need for Nigerians to continue to practice preventive measures to avoid infection.

BLOG COMMENTS POWERED BY DISQUS